BioCorRx Appoints Finance Veteran Joseph J. Galligan to the Board of Directors

ANAHEIM, CA, Feb. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that Joseph J. Galligan was appointed to the Company’s Board of Directors.